Latest News
Exclusive interview with Dr Fadil Bidmos
A better vaccine ecosystem: what does the future hold?
SAGE revises roadmap for COVID-19 vaccination use
Study explores COVID-19 vaccine fatigue determinants
Quadripartite calls for One Health action for “safer world”
CDC warns of “alarming” threat from Candida auris
COVID-19 vaccine not linked to menstruation changes in study
The politics of pandemics: WHO questions data secrecy
WHO offers update on Marburg cases in Equatorial Guinea
Universal oral COVID-19 vaccine protects hamsters in study
Marking World TB Day 2023: “Yes! We can end TB!”
Vaccine equity as good as it sounds, study suggests
China accepts first mRNA vaccine for COVID-19 from CSPC
Africa CDC confirms outbreak of Marburg virus in Tanzania
Vaxxinity starts trial of LDL cholesterol vaccine candidate
Vaccitech announces “promising” data for HPV vaccine
SpyBiotech granted funding for SpyVector platform project
Exclusive interview with Dr Niranjan Sardesai
RVAC and Penn collaborate on possible mRNA therapies
WHO weighs in on new SARS-CoV-2 data from China
Vaccine-derived polio: Burundi and DRC start investigations
A GBS vaccine could save lives and money, say researchers
Uganda’s plan to vaccinate children against yellow fever
LG Chem wins bid to supply essential vaccines for children
GSK’s 5-in-1 Meningococcal vaccine shows promise in trial
Experts call for change in the epidemic ecosystem
Exclusive interview with Dr Ike James
Thermostable tuberculosis vaccine meets Phase I goals
Study suggests sleep key to successful vaccine responses
VIE awards 2023: the final shortlist announced!
Researchers in Israel develop mRNA vaccine against bacteria
Will cell-free processes accelerate vaccine development?
Lassa vaccine in monkeys: protection not therapy
Exclusive interview with Dr Yongjun Sui
GSK “delighted” by VRBPAC vote on RSV candidate
Pfizer “encouraged” by VRBPAC vote on RSV candidate
Exclusive interview with Dr Mark Feinberg
WHO issues update on avian flu in Cambodia
Ghana confirms two cases of Lassa fever in Accra
WHO issues update on Marburg in Equatorial Guinea
FDA requests research into Pfizer’s RSV GBS risk
Queensland’s quest for an Australian cattle vaccine
Maternal vaccination information in New Zealand
Concern after avian influenza kills child in Cambodia
The Measles and Rubella Initiative enters “new era”
LinKinVax welcomes HIV candidate Phase I results
Moderna and Merck granted BTD for cancer therapy
When pigs fly – or vaccinate themselves against Salmonella
Funding Australian efforts for mRNA Strep A vaccine
Synthetic squalene: a sustainable alternative to shark?
African leaders unite on routine immunisation goals
World Vaccine Congress Washington: meet our start-ups!
Montenegro’s “Health Caravan” promotes immunisation
BactiVac secures £1 million in Wellcome funding
Scancell announces “encouraging” early Modi-1 data
Dr Jean Kaseya appointed Director General of Africa CDC
French study explores vaccination and housing situation
Pfizer and Valneva issue update on Lyme vaccine trial
US researchers develop platform for viral pathogens
Exclusive interview with the US BIOLOGIC team
Moderna announces “mixed” interim flu results
CEPI supports Sudan ebolavirus antibody standard
Mpox: still a PHEIC, says IHR Emergency Committee
Gritstone bio and NCI collaborate on clinical trial
VBI Vaccines announces Phase II data for HBV therapy
WHO responds to Nature “error in reporting” article
One Health approaches: the agricultural perspective
Nature: WHO investigation into pandemic origin dropped
Bavarian Nordic announces Emergent travel vaccine agreement
World Vaccine Congress Washington: meet our start-ups!
Vaxart announces start of Phase II norovirus trial
US and Novavax announce modified COVID-19 agreement
Equatorial Guinea confirms outbreak of Marburg virus
Gavi appoints Dr Muhammad Ali Pate as CEO
Health inequity or vaccine hesitancy: understanding barriers
New diagnostic test identifies virus types and strains
SK bioscience launches R&PD Centre for global health
Challenges and opportunities of VLP-based vaccines
Concern grows as avian flu affects more mammals
Maternal Tdap vaccine reduces pertussis in infants
Exclusive interview with Dr Francesca Micoli
UNEP report “Bracing for Superbugs”: AMR and One Health
Gerresheimer and Corning partner on Velocity Vials
Africa CDC hosts Biomanufacturing Workforce workshop
UK MHRA grants Takeda authorisation for Dengue vaccine
World Vaccine Congress Washington: meet our start-ups!
mRNA sights shift to universal flu potential
Pharma companies ride the economic wave of 2022
The Pandemic Fund invites submissions for projects
UK announces progress on bovine TB vaccine and test
NIH researchers develop promising SUDV vaccine
Exclusive interview with Dr Ofer Levy last year
Bird flu affecting otters and foxes in the UK
CEPI to support 20Med mRNA vaccine technology
African leaders vow to end AIDS in children by 2030
IVAC runs vaccine hesitancy training course in India
The 100 days mission: UKHSA assumes responsibility
Cancer vaccines strengthened against aggressive tumours
World Vaccine Congress Washington: meet our start-ups!
Moderna secures FDA Breakthrough Therapy Designation for RSV
White paper from IAVI: vaccine partnerships for EIDs
Marburg vaccine candidate shows in-human promise
WHO in January 2023: COVID-19 still a PHEIC
World Neglected Tropical Diseases Day 2023: WHO’s report
AC Immune Alzheimer’s vaccine shows promise in early trials
COVID-19 vaccine strategies: the UK and US plan ahead
Sierra Leone receives CoVDP support worth $2.8 million
Conversations with AI: we spoke to ChatGPT about vaccines
White paper from MMIP: UK Life Sciences Vision
World Vaccine Congress Washington: meet our start-ups!
Vaccine Industry Excellence awards now open for voting!
WHO launches 2023 funding appeal for $2.54 billion
Cervical cancer awareness: UKHSA promotes HPV vaccine
Vaccines Europe pipeline review highlights key candidates
Avian flu detected in farmed minks in Spain
LinKinVax and Gustave Roussy collaborate for human trial
Report shows increase in US pharmacy vaccine administration
CEPI and IPD announce partnership for Global South
INTERCOVID-2022 study: vaccination a pregnancy priority
Janssen’s HIV vaccine hopes dashed in Phase III study
Moderna meets RSV endpoints for older adults
WHO to establish TB Vaccine Accelerator Council
CEPI to provide $4.3m for Vaxxas’ HD-MAP technology
EnsiliTech raises £1.2m for fridge-free vaccines
Intravacc: positive pre-clinical data for gonorrhoea vaccine
CDC identifies stroke signal but satisfied vaccine is safe
Dr Kim’s pandemic warning identifies 4 gaps
Study shows vaccine effective against COVID-19 brain damage
Uganda declares end of Ebola outbreak after four months
Wellcome Sanger Institute launches virus initiative
White paper from ICON: fortifying for the future
World Vaccine Congress Washington: meet our start-ups!
Nature study: accurate information influences intentions
UN report: childhood loss of early life in 2021
CanSinoBIO announces positive progress with mRNA vaccine
IVI and Batavia sign MoU on vaccine research and development
World Vaccine Congress Washington: meet our start-ups!
UK and BioNTech sign MoU for mRNA cancer therapies
Vaccine Industry Excellence awards now open for nominations!
Dual-action vaccine turns cancer on itself
Bee vaccine granted conditional license by USDA
Exclusive interview with Professor Miles Carroll
Cancer vaccine potential in 2023: mRNA moves forward
EU collaboration for China’s COVID-19 concerns
Vaccines arrive in Haiti as cholera cases continue
The future of COVAX: what did we learn from COVID-19?
Bergstrom’s rules for combating medical misinformation
Global vaccine strategies still failing says Berkley
World Cup worries: whispers of MERS mar the fun
Moderna and Merck meet mRNA melanoma efficacy endpoints
Aspen, CEPI, and Gates commit to African vaccines
Group A strep continues to cause concern in England
Ebola vaccine candidates arrive in Uganda for trials
Study shows circadian rhythms influence immune responses
Ebola: cases decrease before vaccine trials begin
Maternal Zika vaccines urgently needed says Gavi
China’s vaccination challenges: targeting the elderly
Valneva reports positive persistence data for chikungunya
Lassa success from The Vaccine Group and DARPA
COVID-19 vaccine for infants: antibodies persist a year on
Pfizer/Valneva Lyme disease vaccine persists 6 months on
Africa CDC gets mpox vaccine donation from Republic of Korea
HDT Bio and UTMB partner against CCHFV and NiV
Marking World AIDS Day 2022: “equalise” theme
US announces further Global Health Security Partnerships
PharmaJet announces grant from NIH for HPV
WHO approval for Republic of Korea regulator
CEPI collaboration with UQ on Disease X platform
WHO: Monkeypox virus gets rebranded as Mpox
Exclusive interview with Dr Ariel Weinberger
UK applies Vaccine Taskforce model to health problems
Group A strep kills child in England with another recovering
Universal flu vaccine hopes renewed in new data
WHO declares measles a dangerous “growing threat”
Relief from UTIs offered by sublingual vaccine
Vaccines: the missing piece in the dementia puzzle?
Exclusive interview with Dr Stephen Johnston
AELIX Therapeutics study in Nature meets endpoints
WHO launches AMR strategy in Africa during awareness week
Exclusive interview with Dr Andrew Vaillant
Glioblastoma vaccine offers longer life to patients
Exclusive interview with Dr Erin Spiegel
WHO on vaccine safety: it’s a “shared responsibility”
Hepatitis E vaccination campaign offers hope in South Sudan
WHO publishes Global Vaccine Market Report 2022
Fentanyl vaccine shows therapeutic promise in rats
A very modern challenge: The Human Immunome Project
Breast cancer vaccine: safe at Phase I trial
New collaboration: AI steps up to pandemic plate
Exclusive interview with Dr Christian Brander
WHPA and WHO sign memorandum of understanding
LUMC and ISA study generates “strong” results
Exclusive interview with Dr Carl Dieffenbach
GSK Shingrix vaccine success drives ¾ revenues
Study shows vaccine confidence sinking after COVID-19
Senescent cell potential against cancer revealed
CEPI-Gavi-WHO collaboration during Ebola outbreak
Nature study: vaccine selfishness cost lives
Calls for ASEAN AVRF to move forward from COVID-19
Vaxxinity platform aims to conquer chronic diseases
Exclusive interview with Dr Jerome Kim
Thinking bee: oral vaccination against AFB in honeybees
Sanofi deploys Dassault’s virtual twin experiences
WHO publishes first list of fungal priority pathogens
Ukraine receives 700,000 Td doses from UNICEF
Senegal launches programme for measles and rubella vaccine
On Polio Day PharmaJet announces USAID grant
British farmers call for bird flu vaccinations
Gavi CEO calls for vaccine market “interventions”
Merck finds frozen Ebola vaccines to test in Uganda spread
WHO and IDIA renew agreement for health impact
African swine fever: the deadly pig pandemic
Cholera vaccine supply issues disrupt double-dose regime
Exclusive interview with Dr Jerald Sadoff
Vaccine efforts: the thorn in Polio’s side?
WHO launches One Health Joint Plan of Action
Airfinity predicts jab price increase to meet demand
BioNTech founding duo anticipate mRNA against cancer
GSK announces positive results for RSV candidate
Reports of increasing dangerous pathogen labs
Japan’s 100-day ambitions funded in SCARDA
Cancer therapy or prevention: where should we focus?
Mouse model mRNA success for hereditary tyrosinemia 1
Oxford study shows meningitis vaccine leads to herd immunity
Menstruation after COVID-19 vaccination: tracking changes
US study: adults believe vaccine is protective against flu
CEPI announces funding for intranasal vaccines
Oxford study reveals lung change after COVID-19
South African vaccine attempt slammed by pharma giants
Moderna denies China access to vaccine technology
Australian collaborators awarded contract for TB vaccines
Gavi reports vaccine drop in 2021 but 2022 shows promise
Zika vaccine technology shows mouse model promise
Vaxxas to receive further funding for patch technology
Misinformation and myths: identifying key culprits
Gates Foundation announces grants for maternal vaccines
Marking World Heart Day 2022: healthy hearts and vaccines
Looming “twindemic” prompts calls for more shots
Still searching for vaccines: mRNA against cancer
Marking World Rabies Day 2022: One Health, Zero Deaths
Sanofi: single-use systems offer speedier manufacturing
Immune imprinting: a help or a hindrance?
Exclusive interview with Dr Charlie Weller
WHO announces 2023 influenza vaccine recommendation
Exclusive interview with Dr Miguel Sanjuan
Sabin announces further BARDA funding for trials
Long Covid: more questions than answers, studies suggest
Global Fund Partners announce record funding against disease
Uganda declares Ebola outbreak of ‘Sudan’ strain
CEPI launches funding for Rift Valley fever trials
White paper from SGS: vaccine development post-pandemic
European biotechs receive EUREKA therapeutic funding
Fauci’s warning: politics disrupts childhood immunisation
Biden declares pandemic over, sends shares plummeting
Marking WHO’s World Patient Safety Day 2022
mRNA giants launch therapeutic protein ambitions
Holding out hope: a therapeutic prostate cancer vaccine
World Vaccine Congress Europe 2022: meet our start-ups!
HHS announces $20 million contract for faster distribution
COVID marathon end in sight, says WHO Director General
Inventprise to launch pneumonia vaccine with Gates support
Pfizer’s Phase III flu trial begins in US
Genexine announces DNA vaccine for cervical cancer
Q Fever cases increase in Queensland, Australia
WHO approves PharmaJet NFIS for polio campaigns
Prof. Hotez: malnutrition vaccines for a hungry world
New COVID boosters: a risk to vaccine confidence?
CEPI funding COVID vaccine research and development
NIAID announces JYNNEOS monkeypox vaccine trial
New HIV strategy in adjuvanted vaccine study
Pfizer’s GBS6 receives Breakthrough Therapy Designation
Positive results in trial for malaria vaccine from Oxford
Oncolytic viruses hold immunotherapy potential
Exclusive interview with Professor Carlos A. Guzman
WHO launches vaccine development portal: STI Watch
CanSino Biologics announces NMPA approval of inhaled booster
Tomato flu: a mystery no more, say experts
PAHO monitors bilateral pneumonia in Argentina
Australian therapy centre provides pandemic solutions
Floods in Pakistan present disease potential, warns UN
Pregnancy misinformation prevails but vaccine still safe
IAVI announces beginning of Lassa trial with CEPI
From Africa, for Africa: Aspen and Serum partnership
VACCELERATE partners explore vaccine outreach
Lung fluid offers cancer diagnostic and treatment options
Control/elimination/eradication: Covid-19/monkeypox/polio
Antiretroviral approved for drug resistant HIV treatment
Pfizer and BioNTech respond to Moderna’s lawsuits
Takeda’s dengue vaccine approved in Indonesia
Moderna files lawsuits against Pfizer and BioNTech
Pfizer announces RENOIR RSV Phase III data
Tomato flu affecting more children across India
GREENER Pharma: the criteria for sustainable healthcare
Shooting for the moon: cancer therapies from CLS
WHO approval for Chinese vaccine regulator
University students reminded to check jabs off their list
HDT Bio’s saRNA collaboration advances cancer technology
Oxford group investigates potential monkeypox therapy
Valneva’s progress towards chikungunya vaccine
Launch of Rotavirus vaccine in Nigeria celebrated globally
One Health research proposals in South-East Asia
Oxford study explores resistance to cancer therapy
WHO Ebola guideline coincides with DRC case
Study in Nature explores mRNA Covid-19 vaccine and HIV
World Vaccine Congress Europe 2022: meet our start-ups!
GSK awarded malaria vaccine contract by UNICEF
Malawi’s cholera outbreak sustained through winter
Bavarian Nordic capacity increased with US manufacturer
UNITAID’s “Landscape” of tools and strategies
UK’s first human Brucella canis case confirmed
WHO updates guidance for Tuberculosis response
UK’s JCVI updates Covid-19 booster programme
White paper from IDT Biologika: oncolytic viruses
mRNA vaccine for cancer shows promise at Tufts University
Avian influenza restrictions lifted in the UK
UK approves Moderna’s dual vaccine against Covid
University partners find MND therapy potential
White paper from IDT Biologika: viral vectors
Study reveals Covid-19 vaccinations safe for pregnancy
CEPI driving research into monkeypox vaccines
Professor Hotez warns against anti-vaccine activism
Langya (LayV) henipavirus emerges in China
The monkeypox vaccine: how much do we know?
Tired T-cells need TLC to continue fighting cancer
Pan-coronavirus vaccine hopes boosted by cold immunity
Positive partnerships for malaria prevention
AI turns its sights to drug discovery challenges
Climate health is global health, study concludes
Lyme disease vaccine candidate proceeds to Phase III study
Immune system map uncovers therapeutic potential
Improving protein factories for gene therapies
UKHSA under vaccine pressure as monkeypox continues
Antimicrobial resistant bacteria discovered in new-borns
Emerging emergencies require top authority
Monkeypox doses stretched to the limit by NIH scientists
Vertex’s “Fantasy project” with Moderna pushes CF limits
Experimental RSV vaccine promise shown in mice
“Shot to the heart” (of mutating viruses)
2030 AIDS elimination goals for new WHO alliance
Gavi’s reasons to be optimistic: routine rises
Science suggests components for pandemic disruption treaty
Continuing the Covid-19 fight with monoclonal antibodies
Hear from our WVC 2022 speaker: Dr Jennifer Nuzzo
WHO’s new infection guidelines for “key populations”
Northern Europe’s novel hepatitis nightmare
Hear from our WVC 2022 speaker: Dr David Kaslow
Hear from our WVC 2022 speaker: Dr James Crowe
Twist Bioscience turns to monkeypox controls
Back to the past: Polio pops up again in 2022
Prioritising pathogens in a pandemic world
Solving supply chain safety and sustainability concerns
Vaccine inequity strikes Africa once again
Demanding sustainable subscriptions for AMR
China’s antiviral pill: from HIV to Covid-19
Operation Warp Speed is a wrap: farewell to funding
Rabies results from Oxford University trial
Danger ahead! The forgotten pandemic: AIDS
Together against Alzheimer’s: where do we stand?
Vaccine fatigue: are we nearly there yet?
A universally acknowledged flu requires a universal vaccine
Marburg virus: more to come or a fleeting moment?
Expecting the unexpected: preparing for Disease X
AMR – global problems require diagnostic solutions
Noses to the grindstone for nasal vaccines
Clinical tribulations – how can we grow from Covid-19?
VIE: looking back to last year’s winners!
A helping hand from double, double toil and trouble
Vaccines: more than just a “sharp scratch”?
High hopes for collaborative HIV vaccine development
Diabetes developments, Provention and Diamyd
Does EBV hold the key for Multiple Sclerosis?
Fighting hidden threats: vaccines against cancer?
Global vaccine uptake: low, slow, room to grow
Me before you before us: vaccine nationalism
Why are covid vaccinations in pregnant women so low?
Marking World Hepatitis Day, 28th July 2022
Fighting fear with facts or feelings? Vaccine hesitancy.
Monkeypox matters – preventing the next pandemic?
Immune to the science? The ‘5C’ drivers of vaccine hesitancy
MOST POPULAR THIS MONTH


Study explores COVID-19 vaccine fatigue determinants
A study published in Nature Medicine in March 2023 explores the factors associated with so-called “vaccine fatigue”, with a specific focus on the recent vaccination campaigns in response to the COVID-19 pandemic. The authors state that vaccines are “likely to remain...


Quadripartite calls for One Health action for “safer world”
In March 2023 the heads of the Quadripartite organisations working on One Health issued a call for greater global action for a safer world. WHO describes the call as “unprecedented”. The Quadripartite comprises four main agencies collaborating to achieve aims that...


CDC warns of “alarming” threat from Candida auris
In March 2023 the CDC commented on data published in the Annals of Internal Medicine that revealed an “alarming” spread of the emerging fungus Candida auris in healthcare facilities in 2020-2021. It also identified a “concerning” increase in 2021 of the number of...


COVID-19 vaccine not linked to menstruation changes in study
A study released in March 2023 in iScience suggests that COVID-19 infection was a greater factor than COVID-19 vaccination in observed changes to a patient’s menstrual cycle. The researchers identified “substantial public concern” related to “disruption of menstrual...


The politics of pandemics: WHO questions data secrecy
After we reported in March 2023 that possibly critical data concerning the Huanan Seafood Wholesale Market had been quietly released on GISAID, the story has developed with researchers and public health leaders challenging China for not sharing them sooner. With...


WHO offers update on Marburg cases in Equatorial Guinea
Just under a month after the confirmation of an outbreak of Marburg virus disease (MVD) in Equatorial Guinea in February 2023, the WHO has issued an update confirming further cases. The statement from WHO suggests that 8 additional laboratory-confirmed cases have been...


Universal oral COVID-19 vaccine protects hamsters in study
A study in Microbiology Spectrum in March 2023 demonstrated the benefits of an oral vaccine for COVID-19 that could “dramatically improve immunisation rates”. The universal vaccine is based on the nucleocapsid protein, which evolves at a slower rate than the spike...


Marking World TB Day 2023: “Yes! We can end TB!”
On Friday 24th March 2023 the WHO and other organisations and individuals observe ‘World Tuberculosis Day’ with the theme “Yes! We can end TB!”. This uplifting and emphatic statement is intended to “inspire hope” and encourage action among leaders. In particular,...